Invesaro

Stocks Health care CURLF

OTC · Health care

Curaleaf Holdings, Inc. (CURLF)

Curaleaf Holdings, Inc. reported revenue of $1.3B in fiscal 2025, down 5.0% from a year earlier. It posted a net loss of $231.1M. Operating cash flow minus capital spending left $74.3M of free cash flow in fiscal 2025. At June 30, 2026 it held $94.6M in cash against $611.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.

Watch CURLF in 60 seconds
Price
$10.96
-0.73% on the day · September 28, 2026
52-week range $5.40 to $15.15
Revenue (FY2025)
$1.3B
-5.0% year on year
Net margin
-18.2%

What Curaleaf Holdings, Inc. does

Curaleaf Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CURLF.

Revenue and profit by year

Revenue
FY20: $221M $221M FY20FY20: $626.6M $626.6M FY20FY21: $1.2B $1.2B FY21FY22: $1.3B $1.3B FY22FY23: $1.3B $1.3B FY23FY24: $1.3B $1.3B FY24FY25: $1.3B $1.3B FY25
Net income
FY20: -$67.2M -$67.2M FY20FY20: -$57.2M -$57.2M FY20FY21: -$205.9M -$205.9M FY21FY22: -$370.1M -$370.1M FY22FY23: -$281.2M -$281.2M FY23FY24: -$215.4M -$215.4M FY24FY25: -$231.1M -$231.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.3B$25.5M-$231.1M-$0.35$74.3M
2024$1.3B$24.7M-$215.4M-$0.32$71.2M
2023$1.3B$42.9M-$281.2M-$0.39$9.8M
2022$1.3B$65M-$370.1M-$0.52-$88.2M
2021$1.2B$58.6M-$205.9M-$0.29-$230.2M
2020$626.6M$72.4M-$57.2M-$0.18-$113.9M

Full financial statements: income, balance sheet and cash flow

Where CURLF ranks in Health care

Revenue$1.3B
#141 of 742 in Health care · Top 19%
Revenue growth-5.0%
#449 of 529 in Health care · Bottom 15%
Net margin-18.2%
#316 of 541 in Health care · Bottom 42%
Free cash flow margin5.9%
#166 of 488 in Health care · Top 34%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Curaleaf Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 16, 2026
  2. September 16, 2026
  3. September 15, 2026
  4. September 15, 2026
  5. September 14, 2026
  6. September 14, 2026
  7. September 8, 2026
  8. September 8, 2026
  9. September 2, 2026
  10. September 2, 2026

All filings on SEC EDGAR

Questions about CURLF

What does Curaleaf Holdings, Inc. do?

Curaleaf Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CURLF.

Is Curaleaf Holdings, Inc. profitable?

No. In fiscal 2025 it reported a net loss of $231.1M on revenue of $1.3B.

How much revenue does Curaleaf Holdings, Inc. make?

In fiscal 2025 Curaleaf Holdings, Inc. reported revenue of $1.3B. That is 5.0% less than a year earlier.

When did Curaleaf Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 16, 2026.

Similar companies

Compare CURLF with

Compare CURLF with any company

Follow CURLF

Get an email when Curaleaf Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CURLF: get an email when it files

Where the numbers come from

Financial figures are the values Curaleaf Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.